Prescription Information Modernization Act of 2026

The Prescription Information Modernization Act of 2026 allows pharmaceutical manufacturers to provide FDA-approved prescribing information for prescription drugs exclusively through electronic means. To ensure accessibility, the bill requires manufacturers to offer prescribers and dispensers the option to receive paper copies either on a continuing basis or as needed, at no additional cost. The Secretary of Health and Human Services must issue final regulations within one year of enactment to implement these changes and minimize adverse economic impacts on healthcare professionals. A public workshop will be held within two years to discuss optimizing the format and usability of this information, with the new requirements applying to drugs introduced into commerce after a two-year transition period or upon the effective date of the final regulations.